Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
27.26%
↑ 113% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
-204.04%
Historical baseline
| Period | Value |
|---|---|
| 2025 | 27.26% |
| 2024 | -31.37% |
| 2023 | -723.58% |
| 2022 | -292.53% |
| 2021 | 0.00% |